Get started today

Medical Cannabis & Epilepsy

Presented by Dr Philip Blair, MD

About this module:

Epilepsy is a neurological condition that can cause devastating effects on children and adults and their families. There are several aetiological factors, and western pharmaceuticals are not always effective in treating it. Cannabidiol shows much promise in the treatment of epilepsy, as evidenced by human studies. In this presentation, Dr Philip Blair MD explains the factors involved in the aetiology and pathophysiology of epilepsy and how cannabidiol as well as Beta caryophyllene may be able to address these. Dr Blair presents treatment strategies and illustrates his treatment experience with CBD with three case studies. 
This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe the impact of epilepsy from several perspectives.
  • Briefly describe the aetiological factors associated with epilepsy, including how the endocannabinoid system and other factors are involved in its pathophysiology.
  • Explain how cannabidiol (CBD) and Beta caryophyllene may be able to address the pathophysiology of epilepsy and thereby help treat it.
  • Debate the scientific research in relation to efficacy of CBD in the treatment of epilepsy.
  • Apply a prescribing strategy for the treatment of epilepsy, taking into consideration various prescribing considerations.

Dr Philip Blair, MD

Dr. Philip Blair, MD, (Colonel, US Army, retired) is a Family Physician and consultant in disease management in the Northwest USA. He graduated from West Point in 1972, attended the University of Miami School of Medicine, training as an Army Family Physician and serving as a combat physician in the first Gulf War. After medical assignments in three continents and 29 years in uniform, he retired from the Army and has been consulting on complex disease management since 2000.

Dr. Blair has been studying, treating, and lecturing about the human body’s natural endocannabinoid system (ECS) since 2014. His goal is to restore health and performance by enhancing the ECS using diet, exercise, appropriate medications and non-psychoactive therapies.
Created with